Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance

被引:28
|
作者
Wang, Xiaolin [1 ]
Zhang, Jiahui [2 ,3 ]
Cao, Guozhen [2 ,3 ]
Hua, Jinghan [2 ,3 ]
Shan, Ge [1 ,4 ]
Lin, Wenchu [2 ,3 ,5 ]
机构
[1] Univ Sci & Technol China UTSC, Dept Clin Lab, Affiliated Hosp 1,Sch Basic Med Sci,Div Life Sci, Chinese Acad Sci CAS,Key Lab Innate Immun & Chron, Hefei 230027, Anhui, Peoples R China
[2] Chinese Acad Sci, Hefei Inst Phys Sci HIPS, High Magnet Field Lab, Hefei 230031, Anhui, Peoples R China
[3] Univ Sci & Technol China, Hefei 230027, Anhui, Peoples R China
[4] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310016, Zhejiang, Peoples R China
[5] Chinese Acad Sci, Key Lab High Magnet Field & Ion Beam Phys Biol, HIPS, Hefei 230031, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
circRNA; Gastric cancer; Metastasis; miRNA sponge; RNA binding protein; Drug resistance; MESSENGER-RNA; CISPLATIN RESISTANCE; OXALIPLATIN RESISTANCE; PROGRESSION; CIRCRNA; ANGIOGENESIS; EXPRESSION; EXOSOMES; BIOGENESIS; MECHANISMS;
D O I
10.1186/s13046-022-02432-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric cancer (GC) is an aggressive malignancy with a high mortality rate and poor prognosis, primarily caused by metastatic lesions. Improved understanding of GC metastasis at the molecular level yields meaningful insights into potential biomarkers and therapeutic targets. Covalently closed circular RNAs (circRNAs) have emerged as crucial regulators in diverse human cancers including GC. Furthermore, accumulating evidence has demonstrated that circRNAs exhibit the dysregulated patterns in GC and have emerged as crucial regulators in GC invasion and metastasis. However, systematic knowledge regarding the involvement of circRNAs in metastatic GC remains obscure. In this review, we outline the functional circRNAs related to GC metastasis and drug resistance and discuss their underlying mechanisms, providing a comprehensive delineation of circRNA functions on metastatic GC and shedding new light on future therapeutic interventions for GC metastases.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Circular RNAs Interaction with MiRNAs: Emerging Roles in Breast Cancer
    Gong, Liu
    Zhou, XiaoYun
    Sun, Jiping
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (14): : 3182 - 3196
  • [22] Emerging roles of circular RNAs in regulating the hallmarks of thyroid cancer
    Tianjiao Zhou
    Zheng Li
    Yumeng Jiang
    Kaiming Su
    Chuan Xu
    Hongliang Yi
    Cancer Gene Therapy, 2024, 31 : 507 - 516
  • [23] Emerging roles of circular RNAs in osteoporosis
    Chen, Weichun
    Zhang, Baozhong
    Chang, Xiao
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (19) : 9089 - 9101
  • [24] The biogenesis and emerging roles of circular RNAs
    Ling-Ling Chen
    Nature Reviews Molecular Cell Biology, 2016, 17 : 205 - 211
  • [25] Emerging roles of circular RNAs in tuberculosis
    Wang, Qinglan
    Yang, Danni
    Zuo, Yinan
    Wang, Dan
    Li, Weimin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] Emerging roles and context of circular RNAs
    Panda, Amaresh C.
    Grammatikakis, Ioannis
    Munk, Rachel
    Gorospe, Myriam
    Abdelmohsen, Kotb
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2017, 8 (02)
  • [27] Emerging Roles of Circular RNAs in Osteosarcoma
    Wang, Chenyu
    Ren, Ming
    Zhao, Xin
    Wang, Ao
    Wang, Jincheng
    MEDICAL SCIENCE MONITOR, 2018, 24 : 7043 - 7050
  • [28] The biogenesis and emerging roles of circular RNAs
    Chen, Ling-Ling
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2016, 17 (04) : 205 - 211
  • [29] Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance
    Li, Li-Xin
    Hao, Yun
    Dong, Lei
    Qiao, Zhong-Qi
    Yang, Shun-Chao
    Chen, Yan-Duo
    Zhang, Kai
    Wang, Ya-Wen
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2025, 24
  • [30] The emerging role of circular RNAs in drug resistance of non-small cell lung cancer
    Yan, Tinghao
    Tian, Xinchen
    Liu, Fen
    Liu, Qingbin
    Sheng, Qing
    Wu, Jianlin
    Jiang, Shulong
    FRONTIERS IN ONCOLOGY, 2022, 12